BSEM

BioStem Technologies Inc

4.05

Sep 28 • 3:47 PM ET -0.09 (-2.29%)

Healthcare Biotechnology USA Micro NASD

Index	-
Market Cap	72.14M
Enterprise Value	66.40M
Income	-28.29M
Sales	34.59M
Book/sh	1.55
Cash/sh	0.39
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Oct 17, 2003

P/E	-
Forward P/E	-
PEG	-
P/S	2.09
P/B	2.61
P/C	10.36
P/FCF	-
EV/EBITDA	-
EV/Sales	1.92
Quick Ratio	0.76
Current Ratio	0.98
Debt/Eq	0.04
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-1.68
EPS next Y	-1.04
EPS next Q	-0.43
EPS this Y	-387.18%
EPS next Y	45.26%
EPS next 5Y	38.66%
EPS past 3/5Y	14.56% -7.36%
Sales past 3/5Y	90.44% 81.44%
EPS Y/Y TTM	-204.26%
Sales Y/Y TTM	-88.74%
EPS Q/Q	-1431.95%
Sales Q/Q	-83.98%
Earnings	Aug 12 AMC
EPS/Sales Surpr.	-4.00% 24.36%

Insider Own	29.00%
Insider Trans	0.00%
Inst Own	-
Inst Trans	0.00%
ROA	-35.05%
ROE	-74.74%
ROIC	-102.44%
Gross Margin	76.08%
Oper. Margin	-67.47%
Profit Margin	-81.80%
SMA20	0.65%
SMA50	7.68%
SMA200	-9.06%
Trades

Shs Outstand	17.82M
Shs Float	12.66M
Short Float	1.06%
Short Ratio	1.24
Short Interest	0.13M
52W High	8.40 -51.85%
52W Low	2.25 79.70%
Volatility	12.65% 10.94%
ATR (14)	0.45
RSI (14)	51.64
Beta	0.47
Rel Volume	1.57
Avg Volume	107.73K
Volume	164,264

Perf Week	-8.07%
Perf Month	5.06%
Perf Quarter	16.24%
Perf Half Y	-8.59%
Perf YTD	6.17%
Perf Year	-18.53%
Perf 3Y	58.63%
Perf 5Y	211.15%
Perf 10Y	-62.13%
Recom	1.00
Target Price	7.00
Prev Close	4.14
Price	4.05
Change %	-2.29%

Sep-21-26 04:30PM	Terminal1, the operating system built for public companies, announced today that BioStem Technologies, Inc. (NASDAQ: BSEM) has joined the Terminal1 platform (GlobeNewswire) -7.17% -9.55%
Aug-18-26 10:00AM	Sidoti Events, LLC's August Micro-Cap Virtual Conference (ACCESSWIRE) +5.00%
Aug-13-26 01:03AM	BioStem Technologies Inc (BSEM) (Q2 2026) Earnings Call Highlights: Revenue Surges to $7. ... (GuruFocus.com) -18.42%
Aug-11-26 09:25AM	BioStem Technologies Inc (BSEM) Q2 2026 Earnings Report Preview: What To Expect (GuruFocus.com)
Jun-09-26 10:50AM	BioStem Technologies Expands Board with Three Appointments as Nasdaq Uplisting Remains a Key Objective (BSEM) (InvestorsHub)

BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. It offers pre-treatment assessment, cell therapies, anti-aging, and wellness compounds. The company was founded by Andrew Smith Van Vurst, Henry W. Van Vurst IV, and Jason Matuszewski on April 29, 1939 and is headquartered in Pompano Beach, FL.

CEOMr. Jason V. Matuszewski

Chief Financial OfficerMr. Brandon Poe

COO & DirectorMr. Andrew Van Vurst CTBS

Chief Accounting OfficerMr. Michael A. Fortunato CPA

Vice President of Corporate Finance & StrategyMr. Noah Agron

Insider Trading	Relationship	Date	Transaction	#Shares	#Shares Total	SEC Form 4
POE BRANDON	Chief Financial Officer	Sep 15 '26	Option Exercise	1,694	58,062	Sep 17 04:30 PM
SMITH-VAN VURST ANDREW	Chief Operating Officer	Sep 17 '26	Option Exercise	9,574	1,539,809	Sep 17 04:30 PM
SMITH-VAN VURST ANDREW	Chief Operating Officer	Sep 15 '26	Option Exercise	7,622	1,530,235	Sep 17 04:30 PM
Matuszewski Jason	Chief Executive Officer	Sep 17 '26	Option Exercise	16,650	1,303,552	Sep 17 04:30 PM
Matuszewski Jason	Chief Executive Officer	Sep 15 '26	Option Exercise	8,469	1,286,902	Sep 17 04:30 PM
WARRINGTON KENNETH HOWARD JR	Director	Sep 15 '26	Option Exercise	1,694	33,928	Sep 17 04:30 PM
FORTUNATO MICHAEL A	Chief Accounting Officer	Sep 15 '26	Option Exercise	4,234	68,664	Sep 17 04:30 PM
HASSETT BARRY	Chief Commercial Officer	Sep 09 '26	Option Exercise	500	5,003	Sep 11 04:15 PM
UNGRODT JODI	Director	Aug 27 '26	Option Exercise	5,647	11,295	Aug 28 04:15 PM
Glickman Mark A	Director	Aug 27 '26	Option Exercise	7,671	7,671	Aug 28 04:15 PM
LESSER HANNAWAY RAYNA	Director	Aug 27 '26	Option Exercise	7,671	7,671	Aug 28 04:15 PM
WARRINGTON KENNETH HOWARD JR	Director	Aug 27 '26	Option Exercise	5,094	32,234	Aug 28 04:15 PM
SONENREICH STEVEN D	Director	Aug 27 '26	Option Exercise	7,671	7,671	Aug 28 04:15 PM
POE BRANDON	Chief Financial Officer	Aug 11 '26	Option Exercise	10,634	56,368	Aug 20 07:30 PM
FORTUNATO MICHAEL A	Chief Accounting Officer	Aug 09 '26	Option Exercise	970	64,430	Aug 20 07:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BSEM

BioStem Technologies Inc

Upgrade your Finviz experience